Synopsys (SNPS)
(Delayed Data from NSDQ)
$499.12 USD
+3.71 (0.75%)
Updated Oct 4, 2024 04:00 PM ET
Pre-Market: $495.53 -3.59 (-0.72%) 8:32 AM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$499.12 USD
+3.71 (0.75%)
Updated Oct 4, 2024 04:00 PM ET
Pre-Market: $495.53 -3.59 (-0.72%) 8:32 AM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Zacks News
The Zacks Analyst Blog Highlights: Fortinet, Zoom Video Communications, Zscaler, Okta and Synopsys
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Fortinet, Zoom Video Communications, Zscaler, Okta and Synopsys
5 Tech Growth Stocks to Buy as Nasdaq Stages Comeback
by Aniruddha Ganguly
Here we pick five tech stocks that trade on Nasdaq and are positioned to grow on solid prospects.
Major Indexes Post Best Intraday Rebound in 3 Months: 5 Picks
by Nalak Das
The Fed's decision to expand its scope to support credit markets amid the pandemic bolstered market participants' confidence.
Why Synopsys (SNPS) Could Be an Impressive Growth Stock
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Synopsys (SNPS).
5 Top Tech Giants to Buy Despite Recent Stock Market Mayhem
by Nalak Das
The technology sector is holding ground defying coronavirus-induced severe volatility. We have narrowed down our search to five tech stocks that have strong growth potential for 2020.
Synopsys (SNPS) Buys Semiconductor Analytics Firm Qualtera
by Zacks Equity Research
Synopsys (SNPS) acquires Qualtera which provides high-performance industrial big data solutions for semiconductor companies for IC manufacturing and test operations.
S&P 500 Rally Going Strong: 6 Growth Stocks to Buy
by Aniruddha Ganguly
Here we pick six S&P 500 stocks that are well-poised to grow as the U.S. economy rebounds.
S&P 500 Records Historically High 50-Day Rally: 5 Top Picks
by Nalak Das
We have narrowed down our search to five S&P 500 stocks that popped more than 20% in the past month and still have upside.
Will Synopsys Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor of Synopsys
Zacks.com featured highlights include: Synopsys, Tesla, Chemed, Teekay Tankers and West Pharmaceutical Services
by Zacks Equity Research
Zacks.com featured highlights include: Synopsys, Tesla, Chemed, Teekay Tankers and West Pharmaceutical Services
Should You Invest in the Invesco Dynamic Software ETF (PSJ)?
by Zacks Equity Research
Sector ETF report for PSJ
Buy These 5 Low Leverage Stocks to Invest Safely
by Zacks Equity Research
Debt financing is a feasible option as long as the companies succeed in generating a higher rate of return compared to the interest rate
5 Top-Ranked Nasdaq-Listed Tech Stocks to Buy Right Now
by Anirudha Bhagat
The rally in technology stocks has been aiding the Nasdaq Composite for the last two months. Here we choose five technology stocks that are well poised to grow as the U.S. economy partially reopens.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
Synopsys, Acushnet, CrowdStrike, Zoom and Netflix highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Synopsys, Acushnet, CrowdStrike, Zoom and Netflix highlighted as Zacks Bull and Bear of the Day
Bull Of The Day: Synopsys (SNPS)
by Daniel Laboe
Synopsys is the backbone of innovation for global electronics and a safe way to invest in the impending 5G revolution and the resurgence in hyperscale computing
Autodesk (ADSK) Q1 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Autodesk (ADSK) first-quarter fiscal 2021 results reflect higher subscription revenues, gross margin expansion and lower operating expenses despite softness in software spending.
The Zacks Analyst Blog Highlights: NIKE, Workday, Allstate, Synopsys and HP
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NIKE, Workday, Allstate, Synopsys and HP
SNPS or INTU: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SNPS vs. INTU: Which Stock Is the Better Value Option?
Synopsys (SNPS) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Synopsys (SNPS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Company News for May 22, 2020
by Zacks Equity Research
Companies In The News Are: MDT, BJ, SNPS, EXPE.
Top Analyst Reports for NIKE, Workday & Allstate
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NIKE (NKE), Workday (WDAY) and Allstate (ALL).
Synopsys' (SNPS) Q2 Earnings and Revenues Surpass Estimates
by Zacks.com
Synopsys' (SNPS) second-quarter fiscal 2020 results benefit from strong design wins owing to a robust product portfolio.
Synopsys (SNPS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Synopsys (SNPS) delivered earnings and revenue surprises of 23.23% and 2.92%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Synopsys (SNPS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Synopsys (SNPS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.